TITLE

Review: Pressurized metered-dose inhalers are as effective as other handheld inhalers for corticosteroid use in asthma

AUTHOR(S)
Blanchard, Amy R.; Golish, Joseph A.
PUB. DATE
May 2002
SOURCE
ACP Journal Club;May/Jun2002, Vol. 136 Issue 3, p110
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Comments on a study which presented a systematic review of clinical effectiveness of pressurized metered dose inhalers versus other handheld inhaler devices for delivering corticosteroids in asthma. Factors which influence the success or failure of a particular delivery system; Advantages and disadvantages of the available delivery systems.
ACCESSION #
8856111

 

Related Articles

  • Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthma. Brocklebank, David; Wright, John; Cates, Christopher // BMJ: British Medical Journal (International Edition);10/20/2001, Vol. 323 Issue 7318, p896 

    Objective: To determine the clinical effectiveness of pressurised metered dose inhalers (with or without spacer) compared with other hand held inhaler devices for the delivery of corticosteroids in stable asthma. Design: Systematic review of randomised controlled trials. Data sources: Cochrane...

  • Budesonide/formoterol pressurized metered-dose inhaler: a guide to its use in asthma.  // Drugs & Therapy Perspectives;Nov2009, Vol. 25 Issue 11, p1 

    The corticosteroid budesonide and the long-acting β2-adrenoceptor agonist formoterol have been combined into a single pressurized metered-dose inhaler (pMDI). The combination pMDI improves lung function, asthma control, asthma symptoms and asthma-related quality of life outcomes in patients...

  • Aerosol Devices and Asthma Therapy. Berger, William // Current Drug Delivery;Jan2009, Vol. 6 Issue 1, p38 

    Aerosol delivery of asthma medications maximizes local effects in the lung and minimizes systemic effects compared with oral therapy. Both corticosteroids and bronchodilators are available in a variety of delivery devices for the treatment of asthma. The 1987 Montreal protocol requiring the...

  • From inhaler to lung: clinical implications of the formulations of ciclesonide and other inhaled corticosteroids. Nave, Ruediger; Mueller, Helgert // International Journal of General Medicine;2013, Vol. 6, p99 

    Asthma continues to be a global health problem and currently available treatments such as corticosteroids can cause unwanted side effects. Inhaled corticosteroids (ICS) are recommended as first-line therapy for reducing airway inflammation and have a distinct advantage over oral preparations as...

  • Budesonide/Formoterol Pressurized Metered-Dose Inhaler. Lyseng-Williamson, Katherine A.; Simpson, Dene // Drugs;2008, Vol. 68 Issue 13, p1855 

    The corticosteroid budesonide and the long-acting β2-adrenoceptor agonist formoterol have been combined into a single pressurized metered-dose inhaler (pMDI) for use in patients aged ≥12 years with asthma. In well designed 12-week clinical trials in patients with mild to moderate or...

  • Ciclesonide: A Review of its Use in the Management of Asthma. Deeks, Emma D.; Perry, Caroline M. // Drugs;2008, Vol. 68 Issue 14, p1741 

    Summary: Ciclesonide (Alvesco®) is an inhaled corticosteroid used in the preventative treatment of persistent bronchial asthma in adults, adolescents and, in some countries, children. The drug is delivered by a non-chlorofluorocarbon hydrofluoroalkane (HFA) metered-dose inhaler (MDI). In the...

  • Adrenal suppression by inhaled corticosteroids in patients with asthma: A systematic review and quantitative analysis. Wojciechowski, Piotr; Dziewonska, Marta; Rys, Przemyslaw; Kowalski, Marek L. // Allergy & Asthma Proceedings;Jan/Feb2016, Vol. 37 Issue 1, p9 

    Background: Inhaled corticosteroids used for treating persistent asthma can suppress adrenal cortisol secretion. This inhibition of endogenous cortisol secretion is an important marker of systemic steroid activity. Although meta-analyses have demonstrated a dose-dependent suppression of cortisol...

  • Budesonide/Formoterol Pressurized Metered-Dose Inhaler. Lyseng-Williamson, Katherine A; Simpson, Dene // Drugs;2008, Vol. 68 Issue 11, p1855 

    â–´ The corticosteroid budesonide and the long-acting ß2-adrenoceptor agonist formoterol have been combined into a single pressurized metered-dose inhaler (pMDI) for use in patients aged ≥12 years with asthma.â–´ In well designed 12-week clinical trials...

  • Written action plans for asthma: an evidence-based review of the key components.  // Thorax;Feb2004, Vol. 59 Issue 2, p94 

    Background: Written action plans for asthma facilitate the early detection and treatment of an asthma exacerbation. Several versions of action plans have been published but the key components have not been determined. A study was undertaken to determine the impact of individual components of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics